Philadelphia's Transportation Authority has filed a lawsuit against Gilead Sciences over the pricing of its hepatitis C drug. Gilead has been selling a 12-week treatment of Sovaldi in the United States for approximately $84,000, or $1,000 per pill.
The FDA has approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II). This test is intended for use as an additional, more specific test for human serum or plasma specimens that have previously tested positive on an FDA-licensed HTLV-I/II blood donor screening test.
A new website tracks the flu virus by location in an effort to try to prevent infection.
Oncologist and CBS News medical contributor Dr. David Agus discusses a revolutionary approach for the treatment of cancer which was featured on "60 Minutes."
Yassmeen Castanada, 19, is in intensive care after suffering an allergic reaction to a friend's medicine.
The HPR-Micro Reactor™ is ideal for early, exploratory research. It is especially well suited for research, process development, and screening applications when reagents, catalysts, or other essential materials are expensive or available in very limited supply.
The Obama administration says sign-ups picked up last week under the president's health care law. More than 618,000 people selected a plan for 2015 from Nov. 29 through Dec. 5, the Health and Human Services department reported.
Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects. The Hopitaux Universitaires de Geneve said the trial had been suspended "as a precautionary measure." The study involving 59 people began in November.
Vetter has announced that its U.S. early-stage development site located at the Illinois Science + Technology Park in suburban Chicago, has completed the next step of its expansion with the addition of a third cleanroom. Clinical syringe projects are now being accepted at the facility, which can handle preclinical through phase II projects.
Nearly 20 percent of U.S. consumers, 42.9 million people, have unpaid medical debts, according to a new report by the Consumer Financial Protection Bureau. The findings suggest that many Americans are being trapped by debt because they are confused by the notices they get from hospitals and insurance companies about the cost of treatment.
CareerBliss has announced the 5th annual CareerBliss 50 Happiest Companies in America awards list. The list honors the top companies dedicated to creating happier work environments - as voted for by their own employees.
Walgreens announced that Greg Wasson, president and chief executive officer, has informed the company’s board of directors that he will retire shortly after the close of the second step of the Alliance Boots transaction, on which shareholders are scheduled to vote on Dec. 29, 2014.
Enhancing the flexibility of operations is swiftly becoming a major priority for pharmaceutical manufacturers. In Accenture’s 2013 marketing study of leading manufacturers, 82 percent of respondents agreed “the ability to flexibly and dynamically move product from one facility to another or to change the product mix at an existing facility to match demand is critical to achieving our growth goals.”
The FDA has approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by nine types of Human Papillomavirus (HPV). Covering nine HPV types, five more HPV types than Gardasil, Gardasil 9 has the potential to prevent approximately 90 percent of cervical, vulvar, vaginal and anal cancers.
Republicans and Democrats on a House Energy and Commerce subcommittee questioned Wednesday whether requiring a label on any packaged food including genetically modified organisms — or foods grown from seeds engineered in labs — would be misleading to consumers since there is no evidence that such foods are unsafe.